Biotech Crypto News
Biotech crypto news from TLT: 2 original briefs, each synthesised from across 50+ outlets, cross-checked for agreement on the key figures, enriched with live market data and Bitcoin-timestamped for provenance. The latest Biotech developments are below — updated hourly, with the data context no single outlet carries.
Moderna Stock Plummets Despite Positive Melanoma Vaccine Trial Results
Moderna's shares dropped over 17% despite promising Phase 3 results for its personalized melanoma vaccine developed with Merck.
ImmunityBio's ANKTIVA Shows Promise in Bladder Cancer Despite Stock Decline
ImmunityBio's ANKTIVA demonstrates a 71% complete response rate in bladder cancer trials, but the company's stock falls 7.25%.